Evolent Health Inc
EVH
NYSE
Health Care
$3.95
USD
+0.36 (+10.03%)
At close: Aug 7, 2026, 4:00 PM EDT
Market Cap $453.86M
Volume 5.1M
Revenue
$1.89B
TTM
-21.3%
YoY
Gross Margin
20%
TTM
+32.4%
YoY
Net Income
$-496.52M
TTM
-355.7%
YoY
Operating Cash Flow
$33.01M
TTM
+20.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 483.6 | 444.3 | 479.5 | 468.7 | 496.2 |
YoY Growth | -24.4% | -31.3% | -22.8% | -27.5% | +2.6% |
Cost of Revenue | 381.2 | 343.9 | 379.8 | 371.5 | 412.5 |
Gross Profit | 102.5 | 100.4 | 99.8 | 97.3 | 83.8 |
Selling, General & Administrative | 78.4 | 75.2 | 77.6 | 72.7 | 72.8 |
Other Operating Expenses | 0.0 | 3.2 | -2.3 | 402.7 | 0.0 |
Total Operating Expenses | 102.5 | 101.6 | 98.9 | 520.4 | 94.4 |
Operating Income | 0.0 | -1.2 | 0.9 | -423.1 | -10.6 |
EBITDA | 25.3 | 23.3 | 27.7 | 21.7 | 11.9 |
Other Income / Expense | -54.0 | -9.0 | -5.3 | 10.4 | 0.7 |
Total Other Income / Expense | -63.2 | -19.6 | -20.8 | -7.7 | -15.1 |
Income Before Income Taxes | -63.1 | -20.7 | -20.0 | -430.8 | -25.7 |
Income Taxes | 1.5 | -0.8 | 0.9 | -1.7 | 0.9 |
Net Income | -64.6 | -19.9 | -20.9 | -429.1 | -26.6 |
Consolidated Net Income / Loss | -64.6 | -19.9 | -20.9 | -429.1 | -26.6 |
Net Income Attributable to Common Shareholders | -72.3 | -51.1 | -26.9 | -429.1 | -26.6 |
Basic EPS | -$0.63 | -$0.44 | -$0.24 | -$3.76 | -$0.24 |
Diluted EPS | -$0.63 | -$0.44 | -$0.24 | -$3.76 | -$0.24 |
Basic Shares Outstanding | 115.3M | 115.9M | 114.1M | 114.2M | 111.9M |
Diluted Shares Outstanding | 115.3M | 115.9M | 114.1M | 114.2M | 111.9M |